BPC-157: what the research shows

BritishPeps research team · Updated 18 July 2026 · ~6 min read

BPC-157 is one of the most-discussed compounds in peptide research. This guide sets out what the compound is, what questions the laboratory models actually explore, and how it is handled in a research setting. It is purely informational: BPC-157 is supplied exclusively for in-vitro laboratory research and is not for human or veterinary use.

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of fifteen amino acids — derived from a partial sequence of a protein found in gastric juice. It carries CAS number 137525-51-0 and is supplied as a lyophilised powder. Because it is stable and well characterised, it appears often in the experimental literature on cytoprotection and tissue repair. The full written specification, molecular formula and sequence are on the BPC-157 product page.

What do the research models explore?

In published laboratory work, BPC-157 is studied as a reference compound in several areas:

Angiogenesis: the formation of new blood vessels, a key process in how tissue models repair.
Tendon, ligament and muscle-tissue repair: much of the literature draws on connective-tissue models.
Gastrointestinal tissue protection: consistent with the peptide's origin in a gastric protein sequence.
The gut–brain axis: signalling pathways studied in more recent experimental work.

All of this is best read as a description of what scientists are investigating, not as outcomes or benefits for any living thing. Much of this work is preclinical, and the published results remain an active field of study.

How is BPC-157 studied alongside other peptides?

In recovery-focused research, BPC-157 is often examined alongside TB-500 (a thymosin β-4 fragment), because the two are associated with distinct but complementary repair pathways. The pairing is common enough that it appears in ready-made research blends such as GLOW 70 (BPC-157 + GHK-Cu + TB-500) and KLOW 80 (which adds KPV). Blends let a laboratory work with several reference compounds from a single vial.

Laboratory handling and storage

BPC-157 ships lyophilised. Standard laboratory practice is to keep the sealed vial at −20 °C, protected from light and moisture. When needed, it is reconstituted with bacteriostatic water, and from that point the solution is kept refrigerated at 2–8 °C. To work out the concentration from the vial and solvent amounts, use the reconstitution calculator. Our step-by-step reconstitution guide walks through the whole process.

Purity and documentation

For research to be reproducible, the identity and purity of the compound are fundamental. Every BritishPeps vial ships with a written specification and, where applicable, a CAS number, and purity is documented batch by batch (≥98% by HPLC). Consistent documentation is what separates a usable reference compound from an unknown.

Frequently asked questions

Is BPC-157 approved for human use?

No. BPC-157 is supplied exclusively for in-vitro laboratory research and is not approved for human or veterinary use. This article is informational and describes no human use.

What is the difference between BPC-157 and TB-500?

They are different compounds, associated in the research with different repair pathways. BPC-157 is a pentadecapeptide of gastric origin; TB-500 is a thymosin β-4 fragment. They are frequently studied together, which is why blends combine them.

How should BPC-157 be stored?

Keep the lyophilised vial at −20 °C, protected from light. After reconstitution, keep it refrigerated at 2–8 °C.

For research use only. This content is informational and describes laboratory research. The products mentioned are supplied exclusively for scientific and in-vitro laboratory research, not for human or veterinary use. You must be 18 or over to place an order. Each buyer is responsible for complying with the law in their own country.